(1Z)-1-(1H-Indol-3-yl)ethanone oxime
|
- $237 - $752
- Product name: (1Z)-1-(1H-Indol-3-yl)ethanone oxime
- CAS: 40747-13-5
- MF: C10H10N2O
- MW: 174.2
- EINECS:
- MDL Number:MFCD00509588
- Synonyms:(1Z)-1-(1H-Indol-3-yl)ethanone oxime;(Z)-1-(1H-Indol-3-yl)ethanone oxime;Ethanone, 1-(1H-indol-3-yl)-, oxime, (1Z)-;(Z)-1-(1H-indol-3-yl)ethan-1-one oxime
4 prices
Selected condition：
Brand
- American Custom Chemicals Corporation
- Chemenu
- Crysdot
- Matrix Scientific
Package
- 5MG
- 500mg
- 5g
- ManufacturerAmerican Custom Chemicals Corporation
- Product numberCHM0990330
- Product description(1Z)-1-(1H-INDOL-3-YL)ETHANONE OXIME 95.00%
- Packaging5MG
- Price$503.8
- Updated2021-12-16
- Buy
- ManufacturerChemenu
- Product numberCM230291
- Product description(Z)-1-(1H-Indol-3-yl)ethanoneoxime 95%+
- Packaging5g
- Price$711
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD11127797
- Product description(Z)-1-(1H-Indol-3-yl)ethanone oxime 97%
- Packaging5g
- Price$752
- Updated2026-05-26
- Buy
- ManufacturerMatrix Scientific
- Product number064224
- Product description(1Z)-1-(1H-Indol-3-yl)ethanone oxime
- Packaging500mg
- Price$237
- Updated2021-12-16
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| American Custom Chemicals Corporation | CHM0990330 | (1Z)-1-(1H-INDOL-3-YL)ETHANONE OXIME 95.00% | 5MG | $503.8 | 2021-12-16 | Buy |
| Chemenu | CM230291 | (Z)-1-(1H-Indol-3-yl)ethanoneoxime 95%+ | 5g | $711 | 2021-12-16 | Buy |
| Crysdot | CD11127797 | (Z)-1-(1H-Indol-3-yl)ethanone oxime 97% | 5g | $752 | 2026-05-26 | Buy |
| Matrix Scientific | 064224 | (1Z)-1-(1H-Indol-3-yl)ethanone oxime | 500mg | $237 | 2021-12-16 | Buy |
Properties
Boiling point :395.5±15.0 °C(Predicted)
Density :1.22±0.1 g/cm3(Predicted)
pka :11+-.0.10(Predicted)
Density :1.22±0.1 g/cm3(Predicted)
pka :11+-.0.10(Predicted)
Safety Information
| Symbol(GHS): | ||||||||
|---|---|---|---|---|---|---|---|---|
| Signal word: | ||||||||
| Hazard statements: |
|
|||||||
| Precautionary statements: |
|